Cardiac toxicity monitoring for HER2-positive breast cancer patients undergoing trastuzumab therapy: are we doing enough?

Clinical oncology (Royal College of Radiologists (Great Britain))

PubMedID: 23583229

Gujral DM, Lloyd G, Bhattacharyya S. Cardiac toxicity monitoring for HER2-positive breast cancer patients undergoing trastuzumab therapy: are we doing enough?. Clin Oncol (R Coll Radiol). 2013;25(7):446-7.
An abstract is not available. Please access the article through the links below.